We are live on ! Find out more
SVA

Sinovac Biotech, Ltd
SVA

Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

28 hedge funds and large institutions have $118M invested in Sinovac Biotech, Ltd in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

5% less capital invested

Capital invested by funds: $123M → $118M (-$5.73M)

3% less funds holding

Funds holding: 29 → 28 (-1)

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$980

Top Sellers

Rank Fund Capital Flow
1
FIM
Freedom Investment Management
Connecticut
-$2.28K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.29K
3
HI
Harbour Investments
Wisconsin
-$1K

SVA Hedge Fund Activity: Q4 2021 in Review

28 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q4 2021, worth a combined $118M — down 4.6% from $123M a quarter earlier.

Fund positioning in SVA was balanced in Q4 2021: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 2 trimmed.

The largest buyer was Northwestern Mutual Wealth Management, adding an estimated $980. The largest seller was Freedom Investment Management, cutting an estimated $2.28K.

  • 28 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q4 2021, down from 29 in Q3 2021.
  • Funds reported $118M of Sinovac Biotech, Ltd stock for Q4 2021, down 4.6% quarter-over-quarter.
  • 1 fund opened new Sinovac Biotech, Ltd positions in Q4 2021 and 1 closed out, a net change of 0 holders.
  • The largest Sinovac Biotech, Ltd buyer in Q4 2021 was Northwestern Mutual Wealth Management, an estimated $980 added.
  • The largest Sinovac Biotech, Ltd seller in Q4 2021 was Freedom Investment Management, an estimated $2.28K sold.

Based on aggregated 13F filings for Q4 2021.